Psychometric validation of the quality of life Inventory − Disability (QI-Disability) among patients with Lennox-Gastaut syndrome and Dravet syndrome
QI-Disability had mostly satisfactory evidence of validity and reliability for DS and LGS and appears suitable for use in clinical practice and clinical trials.
Authors
- Drishti Shah (ORCID: https://orcid.org/0000-0002-5866-7743)
- Heather Romero (ORCID: https://orcid.org/0000-0001-7558-3720)
- Gregor Gibson
- Jenny Downs (ORCID: https://orcid.org/0000-0001-7358-9037)
- Helen Doll (ORCID: https://orcid.org/0000-0002-1871-8710)
- Hoan Do
- Peter Jacoby
- J. Scott Andrews (ORCID: https://orcid.org/0009-0001-5516-7719)
Institutions
- Eli Lilly (United States) (US)
- The Kids Research Institute Australia (AU)
- Curtin University (AU)
- Adelphi Group (United Kingdom) (GB)
- Takeda (Italy) (IT)
- Health Outcomes Solutions (United States) (US)
- Takeda (United States) (US)
- Takeda (Japan) (JP)
Publication Details
- Journal
- Epilepsy & Behavior
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1016/j.yebeh.2025.110840
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Stan Perron Charitable Foundation